Oncolytics Biotech buy Canaccord Genuity Group Inc.
Start price
06.03.23
/
50%
€1.61
Target price
06.03.24
€4.69
Performance (%)
-
End price
07.03.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten